cell penetrating peptide therapy (Visiogene)

N/A

Report date: 2025/03/19 09:00:27

Base Information

Drug Namecell penetrating peptide therapy (Visiogene)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCorneal fibrosisDiabetic RetinopathyRetinal Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVisiogene LLC
China Registration ClassN/A

Develop Information

Active CompaniesVisiogene LLC
Inactive CompaniesN/A
Active IndicationsCorneal fibrosisDiabetic RetinopathyRetinal Diseases +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A